Capstone Investments initiates coverage on The Medicines Company (Nasdaq: MDCO) with a Buy, price target $11.50.

Capstone analyst says, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE